Target intelligence / Profile preview

Host cell pathways required for early Cytomegalovirus replication

Molecular classification
Enzyme, Transcription factor, Transporter, Receptor, Kinase, Other
01

Overview

Host cell pathways required for early Cytomegalovirus (CMV) replication represent the collective cellular machinery and metabolic processes that the virus exploits to establish infection and initiate genome synthesis. Upon entry, CMV induces a profound metabolic shift known as metabolic reprogramming, significantly increasing glucose uptake and flux through the fatty acid synthesis pathway to provide lipids for viral envelopes (Munger et al., 2008). The virus also hijacks the host's PI3K/Akt/mTOR signaling pathway to ensure robust protein translation and to prevent the cell from undergoing stress-induced apoptosis or autophagy (Buchkovich et al., 2008). Early replication is further dependent on the host's cell cycle control mechanisms, where CMV manipulates cyclin-dependent kinases (CDKs) to create an S-phase-like environment conducive to viral DNA replication (Moorman et al., 2001). Additionally, the virus utilizes host nuclear import and export proteins to transport viral genomes and regulatory proteins between the cytoplasm and the nucleus. Because these pathways are fundamental to host cell survival, drugs targeting them, such as mTOR inhibitors or metabolic antagonists, must be carefully dosed to avoid systemic toxicity. Research into these host factors is driven by the need for host-directed therapies that might be less susceptible to the rapid mutational resistance seen with traditional direct-acting antivirals (Jean Beltran et al., 2016).

Other names
HCMV host dependency factorsHost-virus interactomeCMV host cell requirementsHost factors for Cytomegalovirus replication
02

Mechanism of action

Inhibition of essential host metabolic or signaling pathways to restrict the cellular environment necessary for viral genome replication and protein synthesis.

03

Biological functions

Viral replicationMetabolic reprogrammingSignal transductionProtein synthesisCell cycle regulationMetabolism
04

Disease associations

Infection
05

Safety considerations

Systemic toxicityImmunosuppressionDisruption of normal cellular homeostasisNarrow therapeutic window
06

Interacting drugs

Leflunomide

4 more in the full profile.

07

Biomarkers

Cytomegalovirus DNA loadpp65 antigenemiaHost metabolic flux markers

Beyond the preview

Go deeper on Host cell pathways required for early Cytomegalovirus replication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell pathways required for early Cytomegalovirus replication.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call